Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Nicholson

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Chemistry & Biology|November 29, 2011
Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymesMikael Altun, Holger B Kramer, Lianne I Willems, et al.
Journal of Medicinal Chemistry|December 22, 2011
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structureYuri Yamazaki, Koji Tanaka, Benjamin Nicholson, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Nature Communications|July 5, 2020
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetJoseph W Franses, Julia Philipp, Pavlos Missios, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Molecular Cancer Therapeutics|November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Natalia V Malkova, David Crowe, et al.
Nature Communications|December 19, 2019
Discovery of a chemical probe for PRDM9Abdellah Allali-Hassani, Magdalena M Szewczyk, Danton Ivanochko, et al.
Journal of Medicinal Chemistry|March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of CancerRyan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual InhibitorsXiao Mei Zheng, David A Candito, James Jewell, et al.
BMC Infectious Diseases|June 17, 2021
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2Bianca A Trombetta, Savannah E Kandigian, Robert R Kitchen, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Chemistry & Biology|November 29, 2011
Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymesMikael Altun, Holger B Kramer, Lianne I Willems, et al.
Journal of Medicinal Chemistry|December 22, 2011
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structureYuri Yamazaki, Koji Tanaka, Benjamin Nicholson, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Nature Communications|July 5, 2020
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetJoseph W Franses, Julia Philipp, Pavlos Missios, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Molecular Cancer Therapeutics|November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Natalia V Malkova, David Crowe, et al.
Nature Communications|December 19, 2019
Discovery of a chemical probe for PRDM9Abdellah Allali-Hassani, Magdalena M Szewczyk, Danton Ivanochko, et al.
Journal of Medicinal Chemistry|March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of CancerRyan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual InhibitorsXiao Mei Zheng, David A Candito, James Jewell, et al.
BMC Infectious Diseases|June 17, 2021
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2Bianca A Trombetta, Savannah E Kandigian, Robert R Kitchen, et al.
Pageof 6